Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome

被引:0
|
作者
Legault, Dominic [1 ]
McDermott, John [3 ]
Crous-Tsanaclis, Ana Maria [2 ]
Boire, Gilles [1 ]
机构
[1] CHU Sherbrooke, Dept Med, Div Rheumatol, Sherbrooke, PQ J1H 5N4, Canada
[2] CHU Sherbrooke, Dept Pathol, Sherbrooke, PQ J1H 5N4, Canada
[3] Lakeshore Gen Hosp, Pointe Claire, PQ, Canada
关键词
myositis; autoantibodies; neoplasms; biopsy; major histocompatibility complex;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We describe 3 patients with inflammatory myositis in association with a neoplasm whose serum also contained anti-Jo1 antibodies, one of which presented characteristic features of the antisynthetase syndrome. No patient had a rash, and muscle biopsy was suggestive of polymyositis in all 3. Immunohistochemistry confirmed the diagnosis of polymyositis in the single patient with sufficient tissue available. Our patients remind us that the presence of antisynthetase antibodies (and even antisynthetase syndrome) in a patient with inflammatory myositis does not preclude the diagnosis of cancer-associated myositis.
引用
收藏
页码:169 / 171
页数:3
相关论文
共 50 条
  • [21] High prevalence of necrotising myopathy pattern in muscle biopsies of patients with anti-Jo-1 antisynthetase syndrome
    da Silva, L. M. B.
    Borges, I. B. P.
    Shinjo, S. K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 238 - 246
  • [22] Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease
    Shah, A. A.
    Rosen, A.
    Hummers, L. K.
    May, B. J.
    Kaushiva, A.
    Roden, R. B. S.
    Armstrong, D. K.
    Wigley, F. M.
    Casciola-Rosen, L.
    Visvanathan, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (04) : S71 - S74
  • [23] Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features
    Sherman, Matthew A.
    Graf, Rose
    Sabbagh, Sara E.
    Galindo-Feria, Angeles S.
    Pinal-Fernandez, Iago
    Pak, Katherine
    Kishi, Takayuki
    Flegel, Willy A.
    Targoff, Ira N.
    Miller, Frederick W.
    Lundberg, Ingrid E.
    Rider, Lisa G.
    Mammen, Andrew L.
    RHEUMATOLOGY, 2023, 62 (SI2) : SI226 - SI234
  • [24] The clinical phenotype associated with myositis-specific and associated autoantibodies: A meta-analysis revisiting the so-called antisynthetase syndrome
    Lega, Jean-Christophe
    Fabien, Nicole
    Reynaud, Quitterie
    Durieu, Isabelle
    Durupt, Stephane
    Dutertre, Marine
    Cordier, Jean-Francois
    Cottin, Vincent
    AUTOIMMUNITY REVIEWS, 2014, 13 (09) : 883 - 891
  • [25] SERUM ANTI-MITOCHONDRIAL-AMA, ANTI-TIF1GAMMA, ANTI-RO52 AUTOANTIBODIES CHARACTERIZE CANCER-ASSOCIATED DERMATOMYOSITIS
    Ceribelli, A.
    Tonutti, A.
    Isailovic, N.
    De Santis, M.
    Selmi, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1644 - 1645
  • [26] Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients
    Hulejova, H.
    Krystufkova, O.
    Mann, H.
    Klein, M.
    Pavlickova, K.
    Zamecnik, J.
    Vencovsky, J.
    Senolt, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 222 - 229
  • [27] Anti-transcriptional intermediary factor 1 gamma antibodies in cancer-associated myositis: a longitudinal study
    Dani, L.
    Holmqvist, M.
    Martinez, M. A.
    Trallero-Araguas, E.
    Dastmalchi, M.
    Svensson, J.
    Labrador-Horrillo, M.
    Selva-O'Callaghan, A.
    Lundberg, I. E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (01) : 67 - 73
  • [28] The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis
    Vanessa Posener de Andrade
    Fernando Henrique Carlos De Souza
    Gustavo Luiz Behrens Pinto
    Samuel Katsuyuki Shinjo
    Advances in Rheumatology, 61
  • [29] The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis
    de Andrade, Vanessa Posener
    De Souza, Fernando Henrique Carlos
    Behrens Pinto, Gustavo Luiz
    Shinjo, Samuel Katsuyuki
    ADVANCES IN RHEUMATOLOGY, 2021, 61 (01)
  • [30] Tumour TIF1 mutations and loss of heterozygosity related to cancer-associated myositis
    Pinal-Fernandez, Iago
    Ferrer-Fabregas, Berta
    Trallero-Araguas, Ernesto
    Balada, Eva
    Martinez, Maria Angeles
    Milisenda, Jose Cesar
    Aparicio-Espanol, Gloria
    Labrador-Horrillo, Moises
    Garcia-Patos, Vicente
    Grau-Junyent, Josep M.
    Selva-O'Callaghan, Albert
    RHEUMATOLOGY, 2018, 57 (02) : 388 - 396